Screening anaphylactic components of MaiLuoNing injection by using rat basophilic leukemia-2H3 cell membrane chromatography coupled with HPLC-ESI-TOF-MS

被引:21
作者
Han, Shengli [1 ,2 ]
Lv, Yanni [1 ,2 ]
Xue, Wenjing [1 ,2 ]
Cao, Jiao [1 ,2 ]
Cui, Ronghua [1 ,2 ]
Zhang, Tao [1 ,2 ]
机构
[1] Xi An Jiao Tong Univ, Sch Pharm, 76 Yanta West Rd, Xian 710061, Peoples R China
[2] Natl Prov Joint Engn Res Ctr Nat Vasc Med Screeni, Xian, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Anaphylactic components; Cell membrane chromatography; Harpagoside; Ion trap mass spectrometry; MaiLuoNing injection; PERFORMANCE LIQUID-CHROMATOGRAPHY; FACTOR RECEPTOR ANTAGONISTS; INDUCED HISTAMINE-RELEASE; TANDEM MASS-SPECTROMETRY; ONLINE;
D O I
10.1002/jssc.201500831
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
MaiLuoNing injection is a traditional Chinese medicine that used clinically since the 1950s in China. However, anaphylactic reactions, through the potentiation of mast cell degranulation, have been reported. In the present study, a rat basophilic leukemia-2H3 cell membrane chromatography coupled with high-performance liquid chromatography and electrospray ionization-ion trap-time of flight-mass spectrometry method was established for screening, analyzing, and identifying the potential anaphylactic components of MaiLuoNing injection. Harpagoside, a potential degranulator of rat basophilic leukemia-2H3 cells, was retained in rat basophilic leukemia-2H3 cell membrane chromatography. We aimed to evaluate the retained components to determine which of those were capable of inducing degranulation of basophilic leukemia cells. A beta-hexosaminidase assay revealed that harpagoside can induce rat basophilic leukemia-2H3 cell degranulation in a dose-dependent manner. BLBA/c mice also exhibit passive cutaneous anaphylaxis in response to harpagoside. These results indicate that rat basophilic leukemia-2H3 cell membrane chromatography coupled with high-performance liquid chromatography and electrospray ionization ion trap time-of-flight mass spectrometry is effective in screening for the anaphylactic components of MaiLuoNing injection.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 32 条
[21]   A combined cell membrane chromatography and online HPLC/MS method for screening compounds from Radix Caulophylli acting on the human α1A-adrenoceptor [J].
Wang, Lan ;
Ren, Jing ;
Sun, Meng ;
Wang, Sicen .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (05) :1032-1036
[22]   A new A431/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening epidermal growth factor receptor antagonists from Radix sophorae flavescentis [J].
Wang, Sicen ;
Sun, Meng ;
Zhang, Yanmin ;
Du, Hui ;
He, Langchong .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (32) :5246-5252
[23]   Experimental study on anaphylaxis of Qingkailing injection and its components on Beagle dogs [J].
Wang, Zhiguo ;
Wang, Danqiao ;
Sul, Yu ;
Cui, Haifeng ;
Yu, Youhua .
JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2012, 32 (04) :641-645
[24]  
Wu Guo-lin, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P1137
[25]   MALDI-TOFMS analysis of coordination and organometallic complexes: a nic(h)e area to work in [J].
Wyatt, Mark F. .
JOURNAL OF MASS SPECTROMETRY, 2011, 46 (07) :712-719
[26]  
Yu A., 2015, J MASS SPECTROM, V50, P567
[27]   Analysis of allergens in tubeimu saponin extracts by using rat basophilic leukemia 2H3 cell-based affinity chromatography coupled to liquid chromatography and mass spectrometry [J].
Zhang, Tao ;
Han, Shengli ;
Liu, Qi ;
Guo, Ying ;
He, Langchong .
JOURNAL OF SEPARATION SCIENCE, 2014, 37 (22) :3384-3391
[28]   Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla [J].
Zhang, Tao ;
Han, Shengli ;
Huang, Jing ;
Wang, Sicen .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2013, 912 :85-92
[29]  
Zhang Xi-Lian, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2807
[30]  
[张尊建 Zhang Zunjian], 2004, [中成药, Chinese Traditional Patent Medicine], V26, P175